Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02076581 · ClinicalTrials.gov registry record
MyoSense- Automated Muscle Hypertonicity Classification System
A clinical trial, sponsored by Great Lakes NeuroTechnologies.
- Completed
- Registry status
- 53
- Enrollment target
NCT02076581: Completed study, sponsored by Great Lakes NeuroTechnologies.
NCT02076581 is a clinical trial that has completed, run by Great Lakes NeuroTechnologies. The registered enrollment target is 53 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02076581 has completed, sponsored by Great Lakes NeuroTechnologies.
- COMPLETED
- Registry status
- 53 participants
- Enrollment target
Study Summary
It is often difficult to quantify and distinguish aspects of abnormal muscle tone due to neurological injury. This makes it difficult to evaluate therapies that aim to reduce the effects of abnormal muscle tone. This research study will evaluate the feasibility of a clinician worn device to capture and quantify features of spasticity and dystonia.
Primary Outcome
Device measurements of clinician applied force relative to limb manipulation speed will be compared to conventional clinical outcome measures. For example, correlation between the slope of the force to speed profile and clinician evaluated spasticity, Ashworth score, will be calculated.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 53 participants |
| Start Date | 2014-02 |
| Est. Completion | 2015-04 |
What the finished NCT02076581 record still lists
NCT02076581 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 53 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02076581 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02076581 about?
NCT02076581 is a clinical study titled "MyoSense- Automated Muscle Hypertonicity Classification System". It is often difficult to quantify and distinguish aspects of abnormal muscle tone due to neurological injury. This makes it difficult to evaluate therapies that aim to reduce the effects of abnormal muscle tone. This research study will evaluate the feasibility of a clinician worn device to capture ...
What is the current status of trial NCT02076581?
This trial is currently completed. The enrollment target is 53 participants. The study started on 2014-02. Estimated completion is 2015-04.
Who is sponsoring clinical trial NCT02076581?
This trial is sponsored by Great Lakes NeuroTechnologies, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04177004 · 53 participants · Phase 1
Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- NCT04199741 · 53 participants · Phase 1
PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56
- NCT04835129 · 53 participants · Phase 2
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
- NCT04913805 · 53 participants · Phase 2
Matching Perfusion and Metabolic Activity in HFpEF
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia